Comparative Study of Three Collagen Membranes: 1 Non-cross-linked and 2 Cross-linked

NCT ID: NCT06944639

Last Updated: 2025-06-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-28

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is being done to compare how quickly three different types of collagen membranes break down when they are exposed to the mouth. These membranes are often used in dental and oral surgery to help with healing and tissue growth. The goal is to find out if one membrane lasts longer than the others, which may help doctors choose the best option for different procedures.

In this study, the membranes will be placed in the mouth in a specific area near the gums of the upper back teeth. The study is designed so that neither the patients nor the researchers evaluating the results will know which membrane is which (this is called a double-blind study). Over time, researchers will measure how much each membrane has broken down. This information may help improve treatment planning and patient outcomes in dental care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study was designed as a double-blinded, single-center, randomized clinical trial. Three different types of collagen membranes, ribose cross-linked (RCL) OSSIX Agile, glutaraldehyde cross-linked (GCL) - BioMend Extend, and non-cross-linked (NCL) Jason MB GmbH, were selected for the study.

During the first visit, digital intraoral impressions and clinical pictures will be taken, periodontal charts filled, and oral hygiene sessions conducted by trained hygienists. Two weeks later, during the second visit, patients will be reexamined to exclude any signs of inflammation. Membranes will be cut to a uniform size of 8\*10 mm by an assistant prior to placement. They will be placed in a randomized mesiodistal order on the buccal mucosa, apical to the gingival margins of maxillary premolar and molar teeth (the future position will be evaluated on the intraoral scanned model). To fix the membranes, a vestibular sling suture without any perforation (PTFE 3/0) will be used. A light-cured periodontal dressing (Barricaid, Dentsply Caulk, Dentsply Int. Inc., York, PA, USA) will be placed on the buccal site to fix a knot and two other points on the membrane to fix it to the suture. Standard intraoral pictures will be taken. Patients will be instructed to avoid hard foods, brushing in the area of the membrane, and excessive movements to prevent dislocation of the structure. The same oral hygiene products will be provided to all patients.

Follow-up visits will be scheduled at 3, 7 and 10 days. At the 10-day follow-up clinical evaluation will be performed to assess any perforation. A set of pictures will be taken. Membranes integrity will be analyzed by two blinded examiners using a Scale.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bone Regeneration

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

All patients will receive the three membranes, placed randomly in different positions
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OSSIX - BioMend - Jason

Possible unique ordering of the 3 different membranes to which participants may be randomized

Group Type ACTIVE_COMPARATOR

Membrane Jason MB GmbH Non-cross-linked (NCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane BioMend Extend Glutaraldehyde cross-linked

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane OSSIX Agile Ribose cross-linked (RCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

BioMend - OSSIX - Jason

Possible unique ordering of the 3 different membranes to which participants may be randomized

Group Type ACTIVE_COMPARATOR

Membrane Jason MB GmbH Non-cross-linked (NCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane BioMend Extend Glutaraldehyde cross-linked

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane OSSIX Agile Ribose cross-linked (RCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

BioMend - Jason - OSSIX

Possible unique ordering of the 3 different membranes to which participants may be randomized

Group Type ACTIVE_COMPARATOR

Membrane Jason MB GmbH Non-cross-linked (NCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane BioMend Extend Glutaraldehyde cross-linked

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane OSSIX Agile Ribose cross-linked (RCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Jason - OSSIX - BioMend

Possible unique ordering of the 3 different membranes to which participants may be randomized

Group Type ACTIVE_COMPARATOR

Membrane Jason MB GmbH Non-cross-linked (NCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane BioMend Extend Glutaraldehyde cross-linked

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane OSSIX Agile Ribose cross-linked (RCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Jason - BioMend - OSSIX

Possible unique ordering of the 3 different membranes to which participants may be randomized

Group Type ACTIVE_COMPARATOR

Membrane Jason MB GmbH Non-cross-linked (NCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane BioMend Extend Glutaraldehyde cross-linked

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane OSSIX Agile Ribose cross-linked (RCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

OSSIX - Jason - BioMend

Possible unique ordering of the 3 different membranes to which participants may be randomized

Group Type ACTIVE_COMPARATOR

Membrane Jason MB GmbH Non-cross-linked (NCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane BioMend Extend Glutaraldehyde cross-linked

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Membrane OSSIX Agile Ribose cross-linked (RCL)

Intervention Type DEVICE

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Membrane Jason MB GmbH Non-cross-linked (NCL)

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Intervention Type DEVICE

Membrane BioMend Extend Glutaraldehyde cross-linked

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Intervention Type DEVICE

Membrane OSSIX Agile Ribose cross-linked (RCL)

The membrane will be stabilized in the oral mucosa using sutures and flowable composite.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 18 years old
* Good overall health (ASA I or ASA II)
* Good oral health

Exclusion Criteria

* Patients with gingival pathologies
* Individuals with uncontrolled chronic diseases or immunocompromised.
* Pregnant Patients
* Patients who are currently breastfeeding
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dentsply Sirona Inc.

INDUSTRY

Sponsor Role collaborator

Andrea Ravida

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andrea Ravida

Assistant Professor and Program director

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrea Ravida, DDS, MS, PhD

Role: PRINCIPAL_INVESTIGATOR

Program Director of the Periodontics and Implant Dentistry Department

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Pittsburgh, School of Dental Medicine

Pittsburgh, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Klinger A, Asad R, Shapira L, Zubery Y. In vivo degradation of collagen barrier membranes exposed to the oral cavity. Clin Oral Implants Res. 2010 Aug;21(8):873-6. doi: 10.1111/j.1600-0501.2010.01921.x.

Reference Type BACKGROUND
PMID: 20666799 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STUDY24100119

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Immediate Implant in Posterior Mandible Region
NCT07027904 NOT_YET_RECRUITING NA